GAGE FRED H has a total of 12 patent applications. Its first patent ever was published in 1989. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and Canada. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are NAT INST OF BIOMEDICAL INNOVATION HEALTH & NUTRITION, ZHU ZHENGLUN and CARIS LIFE SCIENCES SWITZERLAND HOLDINGS GMBH.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 8 | |
#2 | United States | 3 | |
#3 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Computer technology | |
#5 | Foods and drinks | |
#6 | Chemical engineering | |
#7 | Machines |
# | Technology | |
---|---|---|
#1 | Measuring microorganism processes | |
#2 | Microorganisms | |
#3 | Analysing materials | |
#4 | Therapeutic chemical compounds | |
#5 | Medical preparations | |
#6 | Enzymes | |
#7 | Peptides | |
#8 | Specific computer systems | |
#9 | Unspecified technologies | |
#10 | Chemical or physical processes |
# | Name | Total Patents |
---|---|---|
#1 | Gage Fred H | 12 |
#2 | Marchetto Maria C N | 4 |
#3 | Yeo Gene | 3 |
#4 | Scolnick Jonathan | 3 |
#5 | Muotri Alysson | 2 |
#6 | Coufal Nicole | 2 |
#7 | Saijo Kaoru | 1 |
#8 | Wiles Janet | 1 |
#9 | Glass Christopher K | 1 |
#10 | Mcconnell Michael J | 1 |
Publication | Filing date | Title |
---|---|---|
WO2011079307A2 | Methods and compositions for treating neurological disorders | |
US2013315886A1 | Retroelements and mental disorders and methods of measuring l1 retrotransposition | |
US2010235310A1 | Temporally dynamic artificial neural networks | |
WO2010083046A2 | Methods for using next generation sequencing to identify 5-methyl cytosines in the genome | |
WO2010077288A2 | Methods for identifying differences in alternative splicing between two rna samples | |
WO2010065776A2 | Identification of neuroprotective agents using pro-inflammatory human glial cells | |
WO2008051928A2 | Target-oriented whole genome amplification of nucliec acids |